Initial experience of preoperative gemcitabine and cisplatin plus durvalumab followed by resection for high-risk biliary tract cancer.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e16329
Citations
1
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Initial experience of preoperative gemcitabine and cisplatin plus durvalumab followed by resection for high-risk biliary tract cancer.

Matthew H. G. Katz, Yun Shin Chun, Hop S. Tran Cao, Milind M. Javle et al.
1 citations
Journal of Clinical Oncology
Cholangiocarcinoma and Gallbladder Cancer Studies
2.01
article

Initial experience of preoperative gemcitabine and cisplatin plus durvalumab followed by resection for high-risk biliary tract cancer.

Matthew H. G. Katz, Yun Shin Chun, Hop S. Tran Cao, Milind M. Javle, Timothy Eric Newhook, Ching‐Wei D. Tzeng, Shubham Pant, Jean‐Nicolas Vauthey, Elena Panettieri, Antony Haddad, Madhulika Eluri, Zishuo Ian Hu
article en
1 citations

Abstract

No abstract available for this paper.
Journal of Clinical OncologyVol. 43(16_suppl)
The University of Texas MD Anderson Cancer Center (US)
Openalex Percentile: Top 15%
Cholangiocarcinoma and Gallbladder Cancer Studies
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.